JP2015500247A5 - - Google Patents

Download PDF

Info

Publication number
JP2015500247A5
JP2015500247A5 JP2014545038A JP2014545038A JP2015500247A5 JP 2015500247 A5 JP2015500247 A5 JP 2015500247A5 JP 2014545038 A JP2014545038 A JP 2014545038A JP 2014545038 A JP2014545038 A JP 2014545038A JP 2015500247 A5 JP2015500247 A5 JP 2015500247A5
Authority
JP
Japan
Prior art keywords
group
optionally substituted
formula
alkyl
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014545038A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015500247A (ja
JP6047581B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2012/001484 external-priority patent/WO2013082656A1/en
Publication of JP2015500247A publication Critical patent/JP2015500247A/ja
Publication of JP2015500247A5 publication Critical patent/JP2015500247A5/ja
Application granted granted Critical
Publication of JP6047581B2 publication Critical patent/JP6047581B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014545038A 2011-12-06 2012-12-06 金属放射性医薬品のためのケージアミン配位子 Active JP6047581B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161567262P 2011-12-06 2011-12-06
US61/567,262 2011-12-06
PCT/AU2012/001484 WO2013082656A1 (en) 2011-12-06 2012-12-06 Cage amine ligands for metallo-radiopharmaceuticals

Publications (3)

Publication Number Publication Date
JP2015500247A JP2015500247A (ja) 2015-01-05
JP2015500247A5 true JP2015500247A5 (enExample) 2016-01-28
JP6047581B2 JP6047581B2 (ja) 2016-12-21

Family

ID=48573413

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014545038A Active JP6047581B2 (ja) 2011-12-06 2012-12-06 金属放射性医薬品のためのケージアミン配位子

Country Status (8)

Country Link
US (2) US9457107B2 (enExample)
EP (2) EP2788353B1 (enExample)
JP (1) JP6047581B2 (enExample)
AU (1) AU2012350147B2 (enExample)
DK (1) DK2788353T3 (enExample)
ES (1) ES2924289T3 (enExample)
PT (1) PT2788353T (enExample)
WO (1) WO2013082656A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9457107B2 (en) 2011-12-06 2016-10-04 The University Of Melbourne Cage amine ligands for metallo-radiopharmaceuticals
WO2013181697A1 (en) * 2012-06-05 2013-12-12 The University Of Melbourne Bicyclo[6.1.0]non-4-yne compounds suitable for use as linkers in biological applications
US9597643B1 (en) * 2013-10-22 2017-03-21 U.S. Department Of Energy Surface functionalization of metal organic frameworks for mixed matrix membranes
US9422286B2 (en) * 2014-01-27 2016-08-23 Washington University Metal-binding bifunctional compounds as diagnostic agents for Alzheimer's disease
DK3634965T3 (da) 2017-06-06 2023-05-01 Clarity Pharmaceuticals Ltd Radiofarmaceutiske lægemidler, radiobilleddannelsesmidler og anvendelser deraf
AU2019251767B2 (en) * 2018-04-11 2024-07-11 Clarity Pharmaceuticals Ltd Targeting compounds and methods for their production
US11738100B2 (en) 2018-04-11 2023-08-29 Clarity Pharmaceuticals Limited Formulations and kits for radiotherapy and diagnostic imaging
TW202426433A (zh) 2022-09-23 2024-07-01 瑞士商紐利迪姆股份公司 成纖維細胞活化蛋白(fap)抑制劑、fap結合物及其診斷與治療用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0001719A1 (en) 1977-10-26 1979-05-02 The Australian National University Metal complexes, their preparation and production of hydrogen peroxide therewith
WO1995031202A1 (en) 1994-05-17 1995-11-23 Commonwealth Scientific And Industrial Research Organisation Cage compounds, processes for their preparation and their use as antiviral agents
EP1331012A1 (en) 2002-01-29 2003-07-30 BRACCO IMAGING S.p.A. Responsive paramagnetic MRI contrast agents
FI20031528A0 (fi) 2003-10-17 2003-10-17 Ctt Cancer Targeting Tech Oy Terapeuttinen liposomikoostumus ja menetelmä sen valmistamiseksi
US9701694B2 (en) * 2008-12-02 2017-07-11 The University Of Melbourne Nitrogen-containing macrocyclic conjugates as radiopharmaceuticals
WO2010121133A2 (en) * 2009-04-17 2010-10-21 The General Hospital Corporation Multimodal imaging of fibrin
US9457107B2 (en) 2011-12-06 2016-10-04 The University Of Melbourne Cage amine ligands for metallo-radiopharmaceuticals

Similar Documents

Publication Publication Date Title
JP2015500247A5 (enExample)
Zayed et al. Synthesis of novel Schiff’s bases of highly potential biological activities and their structure investigation
Zamani et al. Palladium nanoparticles supported on Fe3O4/amino acid nanocomposite: Highly active magnetic catalyst for solvent-free aerobic oxidation of alcohols
Yang et al. Syntheses and crystal structures of four metal–organic co-ordination networks constructed from cadmium (II) thiocyanate and nicotinic acid derivatives with hydrogen bonds
Zayed et al. Preparation and structure investigation of novel Schiff bases using spectroscopic, thermal analyses and molecular orbital calculations and studying their biological activities
JP2013520418A5 (enExample)
Singh et al. A binuclear Mn (II) complex as an efficient catalyst for transamidation of carboxamides with amines
JP2018517024A5 (enExample)
JP2015500246A5 (enExample)
Murakami et al. Demetalation of metal porphyrins via magnesium porphyrins by reaction with Grignard reagents.
Melha In-vitro antibacterial, antifungal activity of some transition metal complexes of thiosemicarbazone Schiff base (HL) derived from N4-(7′-chloroquinolin-4′-ylamino) thiosemicarbazide
JP2011524871A5 (enExample)
Bikas et al. Syntheses, crystal structures and magnetic studies of new 2D coordination polymers containing dinuclear manganese (II) repetitive units using a ditopic isonicotinhydrazone based N, N, O-donor ligand
Mandal et al. Syntheses, crystal structures, magnetochemistry and catechol oxidase activity of a tetracopper (ii) compound and a new type of dicopper (ii)-based 1D coordination polymer
Nikitina et al. The first heterometallic Cu (II)/Cr (III) complex with an open-chain Schiff-base ligand self-assembled from copper powder, Reineckes salt, ethylendiamine and acetone
Pal et al. Guest dependent reversible single-crystal to single-crystal structural transformation in a flexible Gd (III)-coordination polymer
Maurya et al. Bis (o-vanillin) benzidine (o-v2bzH2) as a binucleating ligand: Synthesis, characterization and 3D molecular modeling and analysis of some binuclear complexes of o-v2bzH2 with copper (II), nickel (II), cobalt (II), manganese (II), zinc (II), samarium (III) and dioxouranium (VI)
Zhu et al. Access to 2-pyridinones comprising enaminonitriles via AgOAc promoted cascade reactions of thioesters with aminomethylene malononitriles
Das et al. Effect of protonated aminopyridines on the structural divergences of M (II)–malonate complexes (M= Cu, Ni, Co)
Lee et al. Selective Fe 2+ ion recognition using a fluorescent pyridinyl-benzoimidazole-derived ionophore
Preiss et al. Mössbauer investigation of Schiff base iron (III) coordination compounds
Hassan et al. Synthesis and characterization of benzohydroxamic acid metal complexes and their cytotoxicity study
Al-Hamdani et al. Preparation, spectral characterization, structural study, and evaluation of antibacterial activity of Schiff base complexes for VOII, CrIII, MnII, ZnII, CdII and CeIII
Pethe et al. Synthetic, spectroscopic and thermal studies of some complexes of unsymmetrical Schiff base ligand
Biswas et al. Two-dimensional supramolecular assembly of phenylmercury (II) and cadmium (II) complexes with a tridentate thiohydrazone NNS donor ligand: Synthesis, coordination behavior and crystal structure